ApicHope Pharmaceutical Co (SZSE:300723) ROCE % : -8.69% (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is ApicHope Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. ApicHope Pharmaceutical Co's annualized ROCE % for the quarter that ended in Jun. 2024 was -8.69%.

ApicHope Pharmaceutical Co ROCE % Historical Data

The historical data trend for ApicHope Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ApicHope Pharmaceutical Co ROCE % Chart

ApicHope Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

14.05

18.43

19.08

12.97

9.71

ApicHope Pharmaceutical Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
ROCE %	Get a 7-Day Free Trial															12.17	11.64	-4.71	16.52	-8.69

ApicHope Pharmaceutical Co ROCE % Calculation

ApicHope Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	281.839	/	( ( (4098.442 - 1208.856)	+	(4405.296 - 1488.994) )	/ 2 )
	=	281.839	/	( (2889.586	+	2916.302)	/ 2 )
	=	281.839	/	2902.944
	=	9.71 %

ApicHope Pharmaceutical Co's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	-261.428	/	( ( (4652.399 - 1563.582)	+	(4501.293 - 1574.361) )	/ 2 )
	=	-261.428	/	( ( 3088.817	+	2926.932 )	/ 2 )
	=	-261.428	/	3007.8745
	=	-8.69 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

ApicHope Pharmaceutical Co (SZSE:300723) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

ApicHope Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of ApicHope Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

ApicHope Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ApicHope Pharmaceutical Co Ltd (SZSE:300723) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

Tianhe District Zhujiang New City Jinsui Road, 17th Floor, Star International Building, Guangdong Province, Guangzhou, CHN, 510623

Website

http://www.gdyph.com

ApicHope Pharmaceutical Co Ltd is a fully integrated, research-oriented pharmaceutical and healthcare company. It is engaged in the research and development, production, and sale of pharmaceutical products. The company focuses on pediatric diseases, recombinant vaccines and chronic diseases.

Executives

Yang De Ming	Independent director
Zhang Ming Yuan	Secretary Dong
Zhang Ying Ying	Supervisors
Li Han Dong	Director
Ke Rui Yu	Supervisors
Zhang Hui Xing	Executives

ApicHope Pharmaceutical Co Headlines

No Headlines